Human/Mouse ELF3 Antibody
R&D Systems | Catalog # AF5787
Key Product Details
Validated by
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human/Mouse ELF3 Antibody
ELF3 in A431 Human Cell Line.
ELF3 was detected in immersion fixed A431 human epithelial carcinoma cell line using 10 µg/mL Human/Mouse ELF3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF5787) for 3 hours at room temperature. Cells were stained with the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Cells on Coverslips.
ELF3 in Human Liver.
ELF3 was detected in immersion fixed paraffin-embedded sections of human liver using Human/Mouse ELF3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF5787) at 3 µg/mL overnight at 4 °C. Before incubation with the primary antibody tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
Detection of Human/Mouse ELF3 by Western Blot.
Western blot shows lysates of PC-3 human prostate cancer cell line, A549 human lung carcinoma cell line, and NIH-3T3 mouse embryonic fibroblast cell line. PVDF membrane was probed with 1 µg/mL of Human/Mouse ELF3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF5787) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF109). A specific band was detected for ELF3 at approximately 42 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Detection of Human ELF3/ESE-1 by Western Blot
Inhibition of the SE-associated key targets attenuated LUAD malignant progression via the suppression of master TFs in CRC model.A–C Perturbation of SE associated key targets, including BRD4, EP300, and CDK7, by small-molecule inhibitors reduced the expression of master TFs significantly at protein levels. D Expressions of master TFs in LUAD cell line PC-9 treated with SE associated targets inhibitors in mRNA level were analyzed by real-time PCR. E Inhibition of invasive and migrate activity by perturbation of SE associated key targets via small molecular inhibitions. PC-9 cells were cultured with indicated small molecular inhibitions and subjected to invasion and migration assays (see “Materials and methods”). Invaded and migrated cells were stained with crystal violet and counted. Representative photographs were shown. F, G Histograms represent the number of invasion or migration cells. H In PC-9 cell lines, alterations of ELF3, EHF, and TGIF1 at protein levels while JQ1 treated for 100 nM 48 h together with or without transfected with overexpression plasmids. GAPDH and beta -actin were used as internal control, the lower panels showed the gray scale ratio of protein (ELF3) to GAPDH and protein (EHF and TGIF1) to beta -actin. *p < 0.05; **p < 0.01; ***p < 0.001. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33070167), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of Human ELF3/ESE-1 by Western Blot
Inhibition of the SE-associated key targets attenuated LUAD malignant progression via the suppression of master TFs in CRC model.A–C Perturbation of SE associated key targets, including BRD4, EP300, and CDK7, by small-molecule inhibitors reduced the expression of master TFs significantly at protein levels. D Expressions of master TFs in LUAD cell line PC-9 treated with SE associated targets inhibitors in mRNA level were analyzed by real-time PCR. E Inhibition of invasive and migrate activity by perturbation of SE associated key targets via small molecular inhibitions. PC-9 cells were cultured with indicated small molecular inhibitions and subjected to invasion and migration assays (see “Materials and methods”). Invaded and migrated cells were stained with crystal violet and counted. Representative photographs were shown. F, G Histograms represent the number of invasion or migration cells. H In PC-9 cell lines, alterations of ELF3, EHF, and TGIF1 at protein levels while JQ1 treated for 100 nM 48 h together with or without transfected with overexpression plasmids. GAPDH and beta -actin were used as internal control, the lower panels showed the gray scale ratio of protein (ELF3) to GAPDH and protein (EHF and TGIF1) to beta -actin. *p < 0.05; **p < 0.01; ***p < 0.001. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33070167), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of Human ELF3/ESE-1 by Western Blot
The regulatory interaction network in CRC model of LUAD-SE-associated TFs is interdependent.A–C, J Expressions of all master TFs in the knockdown of any master TF and validating the efficiency of siRNA targeting to master TFs by both real-time PCR and western blot. D–I Western blot and real-time PCR demonstrating that siRNA co-transfected with pcDNA3.1 could decrease the master TF expression significantly in both protein and mRNA level. This phenomenon could be partly reversed by either of another two master TFs, also could be reversed almost entirely in the combination of another two master TFs. K–M Data are shown as fold enrichments of master TFs promotor sub-regions in each antibody immunoprecipitate, ELF3 antibody (K), EHF antibody (L), TGIF1 antibody (M), over control IgG immunoprecipitate. GAPDH and beta -actin were used as internal control, the lower panels showed the gray scale ratio of protein (ELF3) to GAPDH and protein (EHF and TGIF1) to beta -actin. *p < 0.05; **p < 0.01; ***p < 0.001. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33070167), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human/Mouse ELF3 Antibody
Immunocytochemistry
Sample: Immersion fixed A431 human epithelial carcinoma cell line
Immunohistochemistry
Sample: Immersion fixed paraffin-embedded sections of human liver
Western Blot
Sample: PC-3 human prostate cancer cell line, A549 human lung carcinoma cell line, and NIH-3T3 mouse embryonic fibroblast cell line
Formulation, Preparation, and Storage
Purification
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Calculators
Background: ELF3
Long Name
Alternate Names
Gene Symbol
Additional ELF3 Products
Product Documents for Human/Mouse ELF3 Antibody
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human/Mouse ELF3 Antibody
For research use only
Related Research Areas
Citations for Human/Mouse ELF3 Antibody
Customer Reviews for Human/Mouse ELF3 Antibody
There are currently no reviews for this product. Be the first to review Human/Mouse ELF3 Antibody and earn rewards!
Have you used Human/Mouse ELF3 Antibody?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Antigen Retrieval Protocol (PIER)
- Antigen Retrieval for Frozen Sections Protocol
- Appropriate Fixation of IHC/ICC Samples
- Cellular Response to Hypoxia Protocols
- Chromogenic IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Chromogenic Immunohistochemistry Staining of Frozen Tissue
- Detection & Visualization of Antibody Binding
- Fluorescent IHC Staining of Frozen Tissue Protocol
- Graphic Protocol for Heat-induced Epitope Retrieval
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Graphic Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- ICC Cell Smear Protocol for Suspension Cells
- ICC Immunocytochemistry Protocol Videos
- ICC for Adherent Cells
- IHC Sample Preparation (Frozen sections vs Paraffin)
- Immunocytochemistry (ICC) Protocol
- Immunocytochemistry Troubleshooting
- Immunofluorescence of Organoids Embedded in Cultrex Basement Membrane Extract
- Immunofluorescent IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Immunohistochemistry (IHC) and Immunocytochemistry (ICC) Protocols
- Immunohistochemistry Frozen Troubleshooting
- Immunohistochemistry Paraffin Troubleshooting
- Preparing Samples for IHC/ICC Experiments
- Preventing Non-Specific Staining (Non-Specific Binding)
- Primary Antibody Selection & Optimization
- Protocol for Heat-Induced Epitope Retrieval (HIER)
- Protocol for Making a 4% Formaldehyde Solution in PBS
- Protocol for VisUCyte™ HRP Polymer Detection Reagent
- Protocol for the Fluorescent ICC Staining of Cell Smears - Graphic
- Protocol for the Fluorescent ICC Staining of Cultured Cells on Coverslips - Graphic
- Protocol for the Preparation & Fixation of Cells on Coverslips
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections - Graphic
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections - Graphic
- Protocol for the Preparation and Fluorescent ICC Staining of Cells on Coverslips
- Protocol for the Preparation and Fluorescent ICC Staining of Non-adherent Cells
- Protocol for the Preparation and Fluorescent ICC Staining of Stem Cells on Coverslips
- Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- Protocol for the Preparation of a Cell Smear for Non-adherent Cell ICC - Graphic
- R&D Systems Quality Control Western Blot Protocol
- TUNEL and Active Caspase-3 Detection by IHC/ICC Protocol
- The Importance of IHC/ICC Controls
- Troubleshooting Guide: Immunohistochemistry
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars